Brief: Protara Therapeutics Q4 EPS USD -0.9
13/03/2024 12:00
Mar 13 (Reuters) - Protara Therapeutics Q4 income from operations USD -11.041 million. * Q4 net income USD -10.221 million * Q4 operating expenses USD 11.041 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses